Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationMelphalanThiotepaTransplantation ConditioningGranulocyte Colony-Stimulating FactorStem Cell TransplantationLeukapheresisAntigens, CD34Combined Modality TherapyBone Marrow TransplantationHematologic NeoplasmsCyclophosphamideBlood Component RemovalMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsStem CellsHematopoietic Stem CellsGraft SurvivalTreatment OutcomeBusulfanMyeloablative AgonistsEtoposideLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingRemission InductionBone MarrowRecurrenceCord Blood Stem Cell TransplantationTransplantation ChimeraCarmustineHematopoiesisTissue DonorsBone Marrow CellsSalvage TherapyIfosfamideDisease-Free SurvivalVincristineCytarabineWhole-Body IrradiationAmyloidosisRetrospective StudiesHodgkin DiseaseCytophagocytosisSurvival RateTime FactorsHistocompatibilityNeoplasmsSurvival AnalysisHistocompatibility TestingBlood Cell CountInfectionImmunosuppressive AgentsBlood CellsLeukemiaPlatelet CountVidarabineDoxorubicinRecombinant ProteinsLeukemia, Myeloid, AcuteBone Marrow PurgingTransplantation, IsogeneicPOEMS SyndromeCarboplatinFollow-Up StudiesPrednisoneLymphoma, T-CellLymphomaGraft vs Leukemia EffectMesenchymal Stem Cell TransplantationLiver TransplantationDexamethasoneCytomegalovirus InfectionsAntineoplastic AgentsEmbryonic Stem CellsAnemia, AplasticMyelodysplastic SyndromesBone Marrow DiseasesProspective StudiesFeasibility StudiesImmunophenotypingHematologic DiseasesFatal OutcomeAdult Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionFlow CytometryT-LymphocytesCell DifferentiationCell SeparationBlood DonorsLeukocytes, MononuclearCells, CulturedPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocyte CountHLA Antigens